Hostname: page-component-78c5997874-4rdpn Total loading time: 0 Render date: 2024-11-16T02:15:31.785Z Has data issue: false hasContentIssue false
  • English
  • Français

Written Patient Information on Prescription Drugs: The Evolution of Government and Voluntary Programs in the United States

Published online by Cambridge University Press:  10 March 2009

Stuart L. Nightingale
Stuart L. Nightingale
Affiliation:
U.S. Food and Drug Administration
Get access Rights & Permissions [Opens in a new window]

Abstract

This paper describes the evolution of written patient information on prescription drugs, FDA's patient package insert proposal and its revocation before its implementation in the early 1980s, the status of voluntary and government efforts since that time, and a review of current trends in this area. The burgeoning practice of direct-to-consumer advertising of prescription drugs in the lay press is viewed within the context of these efforts. This paper also reviews the current developments in certain FDA regulated consumer products—over-the-counter drug labeling and nutrition labeling. The current state of patient information in the United States is reviewed in light of programs to improve prescription drug counseling, and current research in this area is discussed.

Type
Special Section: The Rational Use of Therapeutic Drugs
Information
International Journal of Technology Assessment in Health Care , Volume 11 , Issue 3 , Summer 1995 , pp. 399 - 409
Copyright
Copyright © Cambridge University Press 1995

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.American College of Physicians drug information for patients. Annals of Internal Medicine, 1986, 104, 121.Google Scholar
2. Council Directive 92/27/EEC, 1992 O.J. (L 113) 8–12.Google Scholar
3.Directory of prescription medication information and education products, programs and services, Washington, DC: National Council on Patient Information and Education (NCPIE), 1994.Google Scholar
4.Ethical criteria for medicinal drug promotion. Geneva: World Health Organization, 1988.Google Scholar
5.Federal Register (44 FR 40016) 07 6, 1979.Google Scholar
6.Federal Register (45 FR 60785) 09 12, 1980.Google Scholar
7.Federal Register (46 FR 23739) 04 28, 1981.Google Scholar
8.Federal Register (47 FR 39147) 09 7, 1982.Google Scholar
9.Prescription Drug Product Labeling: Medication Guide FDA Unified Agenda, 59(79). Federal Register, N532(l) 33–36 12.44, 04 24, 1994.Google Scholar
10.From the Food and Drug Administration. Journal of the American Medical Association, 1994, 271, 1818.Google Scholar
11.Heyduk, L. J.Medication education: Increasing patient compliance. Journal of Psychosocial Nursing, 1991, 29, 32–35.Google ScholarPubMed
12.Kessler, D.A challenge for American pharmacists. American Pharmacy, 1992, 32, 33–36.Google Scholar
13.Kessler, D.Sounding Board: Communicating with patients about their medications. New England Journal of Medicine, 1991, 325, 1650–52.Google Scholar
14. Meeting of the Joint Subcommittee of the Nonprescription Drugs Advisory Committee and the Arthritis Advisory Committee, 09 8 and 9, 1994, Rockville, Maryland.Google Scholar
15.Morris, L. S., & Schulz, R. M.Patient compliance—An overview. Journal of Clinical Pharmacy and Therapeutics, 1992, 17, 283–295.Google Scholar
16.Nightingale, S. Informing patients about drugs: A challenge to industry, government and the professions. In Currie, M. N. (ed.), Patient education in the primary care setting: Proceedings of the Fifth Annual Conference, 09 1982. Kansas City, MO: St. Mary's Hospital of Kansas City, 1983.Google Scholar
17. Office of the Inspector General, Office of Evaluation and Inspections. Medication Regimens: Causes of Noncompliance. 03 1990.Google Scholar
18.Parade Magazine, Sunday, 10 16, 1994. New York: Parade Publications. (Advertisements for Loratadine [Claritin], Finistride [Proscar], Ketoconazole [Nizoral], and Astemizole [Hismanal].)Google Scholar
19. Public Law No. 101–508, §4401, 11 5, 1990.Google Scholar
20.The rational use of drugs: Report of the Conference of Experts, Nairobi, Kenya, 25–29 November 1985. Geneva: World Health Organization, 1987.Google Scholar
21.Special report on patient prescription medicine information resources. Washington, DC: National Council on Patient Information and Education, 1994.Google Scholar
22.U.S. Department of Health and Human Services. Healthy people 2000. Washington, DC: DHH, in press.Google Scholar